- Home
- DCTH vs HRZN Comparison
DCTH vs HRZN Comparison
Compare DCTH & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- HRZN
- Stock Information
- Founded
- DCTH 1988
- HRZN 2008
- Country
- DCTH United States
- HRZN United States
- Employees
- DCTH 76
- HRZN N/A
- Industry
- DCTH Medical/Dental Instruments
- HRZN Finance/Investors Services
- Sector
- DCTH Health Care
- HRZN Finance
- Exchange
- DCTH Nasdaq
- HRZN Nasdaq
- Market Cap
- DCTH 426.3M
- HRZN 352.9M
- IPO Year
- DCTH N/A
- HRZN 2010
- Fundamental
- Price
- DCTH $11.52
- HRZN $8.28
- Analyst Decision
- DCTH Strong Buy
- HRZN Hold
- Analyst Count
- DCTH 4
- HRZN 5
- Target Price
- DCTH $24.00
- HRZN $9.20
- AVG Volume (30 Days)
- DCTH 873.0K
- HRZN 497.9K
- Earning Date
- DCTH 08-04-2025
- HRZN 07-29-2025
- Dividend Yield
- DCTH N/A
- HRZN 16.26%
- EPS Growth
- DCTH N/A
- HRZN N/A
- EPS
- DCTH N/A
- HRZN N/A
- Revenue
- DCTH $53,850,000.00
- HRZN $98,302,000.00
- Revenue This Year
- DCTH $155.42
- HRZN $1.42
- Revenue Next Year
- DCTH $37.93
- HRZN $4.42
- P/E Ratio
- DCTH N/A
- HRZN N/A
- Revenue Growth
- DCTH 1068.87
- HRZN N/A
- 52 Week Low
- DCTH $7.17
- HRZN $7.09
- 52 Week High
- DCTH $18.23
- HRZN $12.63
- Technical
- Relative Strength Index (RSI)
- DCTH 32.83
- HRZN 76.05
- Support Level
- DCTH $12.11
- HRZN $7.09
- Resistance Level
- DCTH $14.15
- HRZN $7.42
- Average True Range (ATR)
- DCTH 0.57
- HRZN 0.17
- MACD
- DCTH -0.16
- HRZN 0.12
- Stochastic Oscillator
- DCTH 9.67
- HRZN 96.75
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.